Evidence map›Paper›PMID 15722551›Full record

ArticleThe Journal of biological chemistry2005

Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase.

Yehua Gan, Ying H Shen, Jian Wang, Xinwen Wang, Budi Utama, Jing Wang, Xing Li Wang

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 93 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Epigenetic Alterations in Pediatric Sleep Apnea.International journal of molecular sciences · 2021
    Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Epigenetic Mechanisms and Hypertension.Hypertension (Dallas, Tex. : 1979) · 2018
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. The role of epigenetics in the endothelial cell shear stress response and atherosclerosis.The international journal of biochemistry & cell biology · 2015
    Review
  18. Review
  19. Histone deacetylase 1 reduces NO production in endothelial cells via lysine deacetylation of NO synthase 3.American journal of physiology. Heart and circulatory physiology · 2014
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Yehua GanDivision of Cardiothoracic Surgery, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas 77030, USA.
Ying H Shen
Jian Wang
Xinwen Wang
Budi Utama
Jing Wang
Xing Li Wang
Baylor College of Medicine · USMichael E. DeBakey VA Medical Center · US

Funding

NO, Genotype Dependent &Environment Specific RegulationR01HL066053 · NHLBI · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI WANG, XING LI L · 2001 to 2004
$1.5M
NHLBI NIH HHS R01 HL066053NHLBI NIH HHS R01-HL066053NHLBI NIH HHS R01 HL066053-04
6 · The paper itself

Abstract

Histone acetylation plays an important role in chromatin remodeling and gene expression. The molecular mechanisms involved in cell-specific expression of endothelial nitric-oxide synthase (eNOS) are not fully understood. In this study we investigated whether histone deacetylation was involved in repression of eNOS expression in non-endothelial cells. Induction of eNOS expression by histone deacetylase (HDAC) inhibitors trichostatin A (TSA) and sodium butyrate was observed in all four different types of non-endothelial cells examined. Chromatin immunoprecipitation assays showed that the induction of eNOS expression by TSA was accompanied by a remarkable increase of acetylation of histone H3 associated with the eNOS 5'-flanking region in the non-endothelial cells. Moreover, DNA methylation-mediated repression of eNOS promoter activity was partially reversed by TSA treatment, and combined treatment of TSA and 5-aza-2'-deoxycytidine (AzadC) synergistically induced eNOS expression in non-endothelial cells. The proximal Sp1 site is critical for basal activity of eNOS promoter. The induction of eNOS by inhibition of HDACs in non-endothelial cells, however, appeared not mediated by the changes in Sp1 DNA binding activity. We further showed that Sp1 bound to the endogenous eNOS promoter and associated with HDAC1 in non-endothelial HeLa cells. Combined TSA and AzadC treatment increased Sp1 binding to the endogenous eNOS promoter but decreased the association between HDAC1 and Sp1 in HeLa cells. Our data suggest that HDAC1 plays a critical role in eNOS repression, and the proximal Sp1 site may serve a key target for HDCA1-mediated eNOS repression in non-endothelial cells.

Indexed as

AzacitidineDecitabineDNA MethylationHeLa CellsHistone Deacetylase 1Histone Deacetylase InhibitorsHistone DeacetylasesHistonesHumansHydroxamic AcidsNitric Oxide SynthaseNitric Oxide Synthase Type IIIPromoter Regions, GeneticSp1 Transcription FactorAzacitidineDecitabineHDAC1 protein, humanHistone Deacetylase 1Histone Deacetylase InhibitorsHistone DeacetylasesHistonesHydroxamic AcidsNitric Oxide SynthaseNitric Oxide Synthase Type IIINOS3 protein, humanSp1 Transcription Factortrichostatin A

Identifiers

PMID15722551
PMCPMC1283144
OpenAlexW2083977776

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.